Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.

Autor: Olkus A; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Tomczak A; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Berger AK; Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Rauber C; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Puchas P; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Wehling C; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Longerich T; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Mehrabi A; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany., Chang DH; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany., Liermann J; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Schäfer S; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cancer Registry, Heidelberg University Hospital, Heidelberg, Germany., Pfeiffenberger J; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Jäger D; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Michl P; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Springfeld C; Liver Cancer Center Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Dill MT; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. michael.dill@med.uni-heidelberg.de.; Liver Cancer Center Heidelberg, Heidelberg, Germany. michael.dill@med.uni-heidelberg.de.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. michael.dill@med.uni-heidelberg.de.; German Cancer Research Center (DKFZ) Heidelberg, Research Group Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany. michael.dill@med.uni-heidelberg.de.

Publikováno v: Targeted oncology [Target Oncol] 2024 Mar; Vol. 19 (2), pp. 213-221. Date of Electronic Publication: 2024 Feb 28.

Quality of Life Assessment in Patients with Polyposis Syndromes and Ileoanal Surgery: Implications for Comprehensive Care.

Autor: Von Römer, G., Hartong, K., Flock, C., Bugaj, T., Koschny, R., Wehling, C.

Publikováno v: Endoscopy; 2024 Supplement 2, Vol. 56, pS76-S76, 1p

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities.

Autor: Wehling C; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Dill MT; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Olkus A; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Springfeld C; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, National Center for Tumor Diseases, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Chang DH; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, 69120, Heidelberg, Germany., Naumann P; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Longerich T; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany., Kratochwil C; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Nuclear Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Mehrabi A; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany., Merle U; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Pfeiffenberger J; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Rupp C; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Weiss KH; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Internal Medicine, Salem Hospital Heidelberg, Zeppelinstraße 11-33, 69121, Heidelberg, Germany., Mieth M; Liver Cancer Center Heidelberg LCCH, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany. markus.mieth@med.uni-heidelberg.de.; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. markus.mieth@med.uni-heidelberg.de.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Aug; Vol. 147 (8), pp. 2471-2481. Date of Electronic Publication: 2021 Feb 04.

Effects of realistic e-learning cases on students' learning motivation during COVID-19.

Autor: Rahm AK; Heidelberg University Medical School, Heidelberg, Germany.; Department of Cardiology, Heidelberg University Hospital, Heidelberg, Germany., Töllner M; Heidelberg University Medical School, Heidelberg, Germany., Hubert MO; Heidelberg University Medical School, Heidelberg, Germany., Klein K; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Wehling C; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg, Germany., Sauer T; Department of Hematology, Heidelberg University Hospital, Heidelberg, Germany., Hennemann HM; Department of Hematology, Heidelberg University Hospital, Heidelberg, Germany., Hein S; Department of Cardiology, Heidelberg University Hospital, Heidelberg, Germany., Kender Z; Department of Endocrinology, Diabetology and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany., Günther J; Department of Hematology, Heidelberg University Hospital, Heidelberg, Germany., Wagenlechner P; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany., Bugaj TJ; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany., Boldt S; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany., Nikendei C; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany., Schultz JH; Heidelberg University Medical School, Heidelberg, Germany.; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.

Publikováno v: PloS one [PLoS One] 2021 Apr 21; Vol. 16 (4), pp. e0249425. Date of Electronic Publication: 2021 Apr 21 (Print Publication: 2021).

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Autor: Mocci, Giammarco¹ (AUTHOR) giammarco.mocci@gmail.com, Tursi, Antonio^2,3 (AUTHOR) antotursi@tiscali.it, Scaldaferri, Franco^4,5 (AUTHOR) franco.scaldaferri@policlinicogemelli.it, Napolitano, Daniele⁴ (AUTHOR) daniele.napolitano@policlinicogemelli.it, Pugliese, Daniela^4,5 (AUTHOR) daniela.pugliese@policlinicogemelli.it, Capobianco, Ivan⁴ (AUTHOR) ivan.capobianco01@icatt.it, Bartocci, Bianca⁴ (AUTHOR) biancab97@hotmail.it, Blasi, Valentina⁴ (AUTHOR) v.blasi.97@gmail.com, Savarino, Edoardo V.⁶ (AUTHOR) edoardosavarino@gmail.com, Maniero, Daria⁶ (AUTHOR) dariamaniero@gmail.com, Redavid, Carlo⁶ (AUTHOR) carlo.redavid@studenti.unipd.it, Lorenzon, Greta⁶ (AUTHOR) gretalorenzon90@gmail.com, Cuomo, Antonio⁷ (AUTHOR) drcuomo@iol.it, Donnarumma, Laura⁷ (AUTHOR) donnarummalaura@gmail.com, Gravina, Antonietta Gerarda⁸ (AUTHOR) antoniettagerarda.gravina@unicampania.it, Pellegrino, Raffaele⁸ (AUTHOR) raffaele.pellegrino@unicampania.it, Bodini, Giorgia⁹ (AUTHOR) bodini.giorgia@gmail.com, Pasta, Andrea⁹ (AUTHOR) andreapasta93@gmail.com, Marzo, Manuela¹⁰ (AUTHOR) manuelamarzo@gmail.com, Serio, Mariaelena¹¹ (AUTHOR) mariaelena.serio@sanita.marche.it

Publikováno v: Journal of Clinical Medicine. Dec2024, Vol. 13 Issue 23, p7192. 15p.